Placental estriol in urine can be determined by rapid enzymatic hydrolysis, extraction with neutral XAD-2 resin, and quantitation by gas-liquid chromatography, with equilenin as the internal standard. Glucose, methenamine mandelate, hydrochlorothiazide, phenolphthalein, or salicylate do not interfere. Analytical recovery of estriol added to urine was 92-108%. Day-to-day precision (CV), established by 15 replicate analyses at a mean concentration of 21.3 mg/liter, was 6.6%.
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The assessment of urinary placental estriol (E3) in pregnancy, as a measure of fetal well being, is well documented (1, 2). Numerous gas-liquid chromatographic (GLC) methods for urinary E3 determinations have been reported (3) (4) (5) (6) (7) (8) . Most of these methods lack true internal standardization; hence there is no correction for analytical variables-the internal standard is used only for peak quantitation.
Smith and Stitch (8) used phenolphthalein as a true internal standard, but phenolphthalein is a commonly used laxative, and thus may be present in maternal urine.
Interference is reportedly caused by glucose (9, 10),
, and phenolphthalein (9) in the determination of urinary E3 after acid hydrolysis. Interference by salicylate (13) has also been reported when enzymatic hydrolysis is used.
We describe a method that obviates many of these difficulties.
Instrumentation
We used a Model 1200 gas chromatograph equipped with a flame-ionization detector (Varian Aerograph, Walnut Creek, Calif. 94598). The 2-meter glass-coil column, 2 mm i.d. was packed with 3% OV-17 on Chromosorb W HIP, 100/200 mesh size (Varian Aerograph).
Gas flow rates (mi/mm) were: hydrogen 20, air 360, and nitrogen 30. Injector and detector temperatures were maintained at 295 #{176}C. Column temperature was maintained at 280 #{176}C. A Varian strip-chart recorder, Model 2000, was used. Chart speed was 2.5 cm/mm and full-scale response was lmV.
Reagents
Except as noted, the following compounds were obtained from Sigma Chemical Co., St. Louis, Mo. 63178. We used a working standard of 250 mg/liter in methanol.
fi-Glucuronidase
Estriol (estra-1,3,5(10)-triene-3,16a,17fl-triol).
Estrone
(estra-1,3,5(10)-triene-3-ol-17-one).
Estradiol
(estra-1,3,5(10)-triene-3,17$-diol).
16-Epiestriol
(estra-1,3,5( 10)-triene-3,16j3,17$-triol). 
16,1 7-Epiestriol
(estra-1,3,5( 10)-triene-3,16!9,-17a-triol).
6a-Hydroxyestriol
(estra-1 ,3,5(10) -triene-3,6a,-16a,-173-tetrol).
Standard.
We used a working standard of 250 mg each of estriol and equilenin per liter of methanol. We used 1800 kU of 3-glucuronidase per liter of 1.0 mol/liter phosphate buffer, pH 7.0.
Procedure
Add 1.0 ml of buffered enzyme to 5.0 ml of urine. Add 2 drops of chloroform, gently mix, and incubate at 60 #{176}C for 30 mm. Pass the cooled hydrolysate through a column containing hydrated XAD-2 resin, rinse the hydrolysate tube with 5.0 ml of distilled water, and pass the rinsing through the column. After the column has completely drained, expel the XAD-2 resin into a polypropylene tube with gentle air pressure and rinse the column with 10 ml of diethyl ether. Into the tube add diethyl ether to a total volume of 25 ml, 2 drops of concentrated hydrochloric acid, and 0.5 ml of the working internal standard. After shaking the mixture for 10 mm, pour the ether layer into a glass centrifuge tube and evaporate. To the dried residue add 5.0 ml of sodium hydroxide solution (100 g/liter) and 15 ml of diethyl ether/petroleum ether (1/3 by vol). Shake for 5 mm and aspirate the ether layer. Add 1.5 ml of concentrated hydrochloric acid to the sodium hydroxide layer, cool the tube, and add 15 ml of diethyl ether. Shake the tube for 5 mm, remove the ether layer, dry it with sodium sulfate, and evaporate it to dryness. Evaporate a 0.4-mi aliquot of the standards. Add 50 il of dimethylformamide and 120 l of N,O-bis(trimethylsilyi)-trifluoroacetamide to the residues and incubate the tubes at 70 #{176}C for 30 mm. Inject 1-2 u1 of the silylated products into the gas chromatograph for analy-. sis.
Results

Analytical Variables
Hydrolysis.
We established the optimal conditions for the enzymatic hydrolysis by adding various concentrations of the enzyme fl-glucuronidase to 5.0-mi aliquots of pregnancy urine buffered with 1.0 ml of phosphate buffer (1 mol/liter, pH 7.0). For each enzyme concentration, incubation time was varied from 15 to 60 mm and incubation temperature from 25 to 70 #{176}C.
Hydrolysis was complete when 1800 units of $-glucuronidase was used at 60 #{176}C for 30 mm.
A comparison between j3-glucuronidase and an enzyme preparation containing both $-glucuronidase and sulfatase as described by Van de Calseyde et al. (14) revealed that the two methods of hydrolysis were comparable. Results of the linear regression analysis of the two methods of hydrolysis were: slope = 1.059, intercept = -0.92, r = 0.95, n = 20 (x, present method;y, other method).
XAD-2 resin extraction.
The XAD-2 resin columns used in this study will bind up to 0.25 mg of E3 (equivalent to a 5.0 ml aliquot of a 50 mg/liter concentration of E3). At E3 concentrations above 50 mg/liter the column effluents contained significant amounts of E3.
Purification of estrogens.
The estrogens were separated from the neutral steroids by washing the aqueous sodium hydroxide layer with diethyl ether/petroleum ether (1/3 by vol). Figure 1 shows a resulting chromatogram of a maternal urine carried through the procedure.
Interfering Compounds
Chromatographic.
Other naturally-occurring estrogens in pregnancy urine that could potentially interfere are estrone, estradiol, of phenolphthalein glucuronide in the urine are unlikely. Phenolphthalein is carried through the extraction procedure and forms a silyl derivative that elutes as a peak in the chromatogram. However, this peak does not interfere with either the E3 or the internal standard peak.
Salicylate.
Ingested acetylsalicylic acid is excreted as a glucuronide, which has been reported to interfere with enzymatic hydrolysis by substrate competition (13). Four normal pregnancy urines were diluted twofold with urine from a normal man, containing 2.5 g of salicylate giucuronide per liter. These same urines were diluted twofold with a pooled salicylate-free urine from normal men. An average 15% decrease in the apparent E3 concentration was noted in the salicylate-containing urines. However, when the same salicylate-containing urines were determined once again, but using a twofold increase in the -glucuronidase (3600 units) for hydrolysis, the apparent E3 concentrations were comparable to those for the salicylate-free urines. Thus, urines that are known to contain salicylate could be processed by using a twofold increase in fl-glucuronidase.
Methenamine mandelate.
Methenamine mandelate is excreted in the urine as formaldehyde. Formaldehyde reportedly interferes with acid hydrolysis of estrogens (10). Formaldehyde or methenamine mandelate was added to a pregnancy urine in various concentrations up to 1000 mg/liter. Neither interfered with the E3 determination.
Urine background.
Fifteen pregnancy urines were processed without adding the internal standard. There was no significant background near the internal standard.
Accuracy and Precision
Accuracy was evaluated by determining recoveries of known amounts of free and conjugated E3 added to Within-run and day-to-day precision was evaluated by assaying replicate aliquots from a maternal urine. Table  1 shows the results of these studies.
Linearity
Peak height (y) and concentration (x) were linearly related over the range of 0 to 50 mg/liter estriol. The regression analysis of the five linearity curves had a slope of 0.968, and an intercept of 0.498. The CV for the slope of the lines was 6.7%.
Discussion
Of the many published assay methods for placental estriol, few correct for analytical losses by incorporating a valid internal standard, as we have done.
The use of Amberlite XAD-2 neutral resin is an efficient and simple method of extraction. In addition, its use eliminates the necessity of washing the ether extract with alkaline carbonate, a procedure common to many E3 assay methods, intended to remove many strongly acidic, potentially interfering compounds. Coincidentally, the alkalinity of this carbonate solution also removes polar estrogens, such as E3. Our method does not require centrifugation, as phase separation is rapid and complete; no emulsion is formed as it is in most acid hydrolysis procedures and some enzymatic procedures-another potential source of E3 loss during processing.
Rapid enzymatic hydrolysis of the conjugated estrogen eliminates the decreased recovery of E3 caused by glucose, methenamine mandelate, phenolphthalein, and hydrochlothiazide.
Hydrolysis time is comparable to that for acid hydrolysis with the added advantage that enzymatic hydrolysis is less destructive.
The purification step, which separates the phenolic estrogens from the potentially interfering neutral steroids, helps create a more specific method. The short additional time needed to accomplish this separation is well worth the effort. If this purification step is eliminated, if necessary, the method is speeded but will be less specific and less accurate.
